| # | Drug | Count |
|---|---|---|
| 0 | ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR | 61 |
| 1 | PANCRELIPASE | 36 |
| 2 | DORNASE ALFA | 32 |
| 3 | TOBRAMYCIN | 26 |
| 4 | ALBUTEROL SULFATE | 20 |
| 5 | FLUTICASONE PROPIONATE | 18 |
| 6 | AZITHROMYCIN DIHYDRATE | 16 |
| 7 | AZTREONAM | 15 |
| 8 | SODIUM CHLORIDE | 15 |
| 9 | SODIUM CHLORIDE TABLET | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR | 61 | 0.0048 |
| 1 | VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR | 2 | 0.0025 |
| 2 | AZTREONAM | 15 | 0.0021 |
| 3 | DORNASE ALFA | 32 | 0.0016 |
| 4 | LUMACAFTOR AND IVACAFTOR | 10 | 0.0012 |
| 5 | TOBRAMYCIN | 26 | 0.0011 |
| 6 | PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE | 6 | 0.0010 |
| 7 | PANCRELIPASE | 36 | 0.0009 |
| 8 | TOBRAMYCIN SOLUTION | 10 | 0.0008 |
| 9 | TOBRAMYCIN SULFATE | 10 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Recombinant Human Deoxyribonuclease 1 [EPC] | 32 |
| 1 | Aminoglycoside Antibacterial [EPC] | 28 |
| 2 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 24 |
| 3 | Osmotic Laxative [EPC] | 18 |
| 4 | Corticosteroid [EPC] | 17 |
| 5 | Insulin Analog [EPC] | 17 |
| 6 | Proton Pump Inhibitor [EPC] | 13 |
| 7 | Bile Acid [EPC] | 11 |
| 8 | Provitamin D2 Compound [EPC] | 10 |
| 9 | Azole Antifungal [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Recombinant Human Deoxyribonuclease 1 [EPC] | 32 | 0.0016 |
| 1 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 24 | 0.0014 |
| 2 | Aminoglycoside Antibacterial [EPC] | 28 | 0.0006 |
| 3 | Vitamin K [EPC] | 5 | 0.0006 |
| 4 | Bile Acid [EPC] | 11 | 0.0005 |
| 5 | Antihypoglycemic Agent [EPC] | 2 | 0.0005 |
| 6 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |
| 7 | Chloride Channel Activator [EPC] | 3 | 0.0003 |
| 8 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 2 | 0.0002 |
| 9 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |